HanParkMD

PubMed

• Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma.
  Carvalho, A. L., Chuang, A., Jiang, W. W., Lee, J., Begum, S., Poeta, L., Zhao, M., Jerónimo, C., Henrique, R., Nayak, C. S., Park, H. L., Brait, M. R., Liu, C., Zhou,...> ;Cancer Res. 2006 Oct 1
• The role of PGP9.5 as a tumor suppressor gene in human cancer.
  Tokumaru, Y., Yamashita, K., Kim, M. S., Park, H. L., Osada, M., Mori, M., Sidransky, D.> ;Int J Cancer. 2008 Aug 15
• Angiogenic factor signaling regulates centrosome duplication in endothelial cells of developing blood vessels.
  Taylor, S. M., Nevis, K. R., Park, H. L., Rogers, G. C., Rogers, S. L., Cook, J. G., Bautch, V. L.> ;Blood. 2010 Oct 21
• Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer.
  Kim, M. S., Louwagie, J., Carvalho, B., Terhaar Sive Droste, J. S., Park, H. L., Chae, Y. K., Yamashita, K., Liu, J., Ostrow, K. L., Ling, S., Guerrero-Preston, R., De...> ;PLoS One. 2009 Jan 01
• Genome-wide promoter analysis uncovers portions of the cancer methylome.
  Hoque, M. O., Kim, M. S., Ostrow, K. L., Liu, J., Wisman, G. B., Park, H. L., Poeta, M. L., Jeronimo, C., Henrique, R., Lendvai, A., Schuuring, E., Begum, S., Rosenbau...> ;Cancer Res. 2008 Apr 15
• DCC promoter hypermethylation in esophageal squamous cell carcinoma.
  Park, H. L., Kim, M. S., Yamashita, K., Westra, W., Carvalho, A. L., Lee, J., Jiang, W. W., Baek, J. H., Liu, J., Osada, M., Moon, C. S., Califano, J. A., Mori, M., Si...> ;Int J Cancer. 2008 Jun 1
• HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.
  Yamashita, K., Kim, M. S., Park, H. L., Tokumaru, Y., Osada, M., Inoue, H., Mori, M., Sidransky, D.> ;Mol Cancer Res. 2008 Jan
• Alterations of GPI transamidase subunits in head and neck squamous carcinoma.
  Jiang, W. W., Zahurak, M., Zhou, Z. T., Park, H. L., Guo, Z. M., Wu, G. J., Sidransky, D., Trink, B., Califano, J. A.> ;Mol Cancer. 2007
• A promoter methylation pattern in the N-methyl-D-aspartate receptor 2B gene predicts poor prognosis in esophageal squamous cell carcinoma.
  Kim, M. S., Yamashita, K., Chae, Y. K., Tokumaru, Y., Chang, X., Zahurak, M., Osada, M., Park, H. L., Chuang, A., Califano, J. A., Sidransky, D.> ;Clin Cancer Res. 2007 Nov 15
• Quantitative hypermethylation of NMDAR2B in human gastric cancer.
  Liu, J. W., Kim, M. S., Nagpal, J., Yamashita, K., Poeta, L., Chang, X., Lee, J., Park, H. L., Jeronimo, C., Westra, W. H., Mori, M., Moon, C., Trink, B., Sidransky, D.> ;Int J Cancer. 2007 Nov 1
• A p53-type response element in the GDF15 promoter confers high specificity for p53 activation.
  Osada, M., Park, H. L., Park, M. J., Liu, J. W., Wu, G., Trink, B., Sidransky, D.> ;Biochem Biophys Res Commun. 2007 Mar 23
• Increased plasma DNA integrity index in head and neck cancer patients.
  Jiang, W. W., Zahurak, M., Goldenberg, D., Milman, Y., Park, H. L., Westra, W. H., Koch, W., Sidransky, D., Califano, J.> ;Int J Cancer. 2006 Dec 1
• PGP9.5 methylation in diffuse-type gastric cancer.
  Yamashita, K., Park, H. L., Kim, M. S., Osada, M., Tokumaru, Y., Inoue, H., Mori, M., Sidransky, D.> ;Cancer Res. 2006 Apr 1
• N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer.
  Kim, M. S., Yamashita, K., Baek, J. H., Park, H. L., Carvalho, A. L., Osada, M., Hoque, M. O., Upadhyay, S., Mori, M., Moon, C., Sidransky, D.> ;Cancer Res. 2006 Apr 1
• A novel response element confers p63- and p73-specific activation of the WNT4 promoter.
  Osada, M., Park, H. L., Nagakawa, Y., Begum, S., Yamashita, K., Wu, G., Kim, M. S., Trink, B., Sidransky, D.> ;Biochem Biophys Res Commun. 2006 Jan 27
• Differential recognition of response elements determines target gene specificity for p53 and p63.
  Osada, M., Park, H. L., Nagakawa, Y., Yamashita, K., Fomenkov, A., Kim, M. S., Wu, G., Nomoto, S., Trink, B., Sidransky, D.> ;Mol Cell Biol. 2005 Jul
• p63-specific activation of the BPAG-1e promoter.
  Osada, M., Nagakawa, Y., Park, H. L., Yamashita, K., Wu, G., Kim, M. S., Fomenkov, A., Trink, B., Sidransky, D.> ;J Invest Dermatol. 2005 Jul
• PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma.
  Mandelker, D. L., Yamashita, K., Tokumaru, Y., Mimori, K., Howard, D. L., Tanaka, Y., Carvalho, A. L., Jiang, W. W., Park, H. L., Kim, M. S., Osada, M., Mori, M., Sidr...> ;Cancer Res. 2005 Jun 1
• Altered sumoylation of p63alpha contributes to the split-hand/foot malformation phenotype.
  Huang, Y. P., Wu, G., Guo, Z., Osada, M., Fomenkov, T., Park, H. L., Trink, B., Sidransky, D., Fomenkov, A., Ratovitski, E. A.> ;Cell Cycle. 2004 Dec
• Join now to see all